DCF — ST VINCENT MEDICAL CENTER
Enterprise Value: $-1.4B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.4B
Enterprise Value
$-433.5M
PV of Cash Flows
$-940.4M
PV of Terminal Value
$-1.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $826.1M | $-86.2M | -10.0% | $-121.2M | $-110.2M |
| Year 2 | $850.9M | $-80.3M | -9.0% | $-116.3M | $-96.1M |
| Year 3 | $876.4M | $-73.9M | -8.0% | $-111.0M | $-83.4M |
| Year 4 | $902.7M | $-71.6M | -8.0% | $-109.8M | $-75.0M |
| Year 5 | $929.8M | $-71.5M | -8.0% | $-110.8M | $-68.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.4B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$802.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1093585623524142
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5